According to Kala Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -NZ$62.59 M. In 2023 the company made an earning of -NZ$68.21 M an increase over its 2022 earnings that were of -NZ$72.45 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.